AFC
GSK icon

Ares Financial Consulting’s GSK GSK Stock Holding History

Ares Financial Consulting’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25K Buy
81
+47
+138% +$2.49K ﹤0.01% 752
2026
Q1 		$1.9K Hold
34
– – ﹤0.01% 852
2025
Q4 		$1.67K Buy
+34
New +$1.59K ﹤0.01% 684

Other funds holding GSK

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

Ares Financial Consulting's GSK Position: Q2 2026 in Review

Ares Financial Consulting increased its GSK (GSK) stake by 138% in Q2 2026, buying an estimated $2.49K and bringing the position to 81 shares worth $4.25K. The position accounts for ﹤0.01% of the portfolio, ranked #752.

Ares Financial Consulting first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. 576 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Ares Financial Consulting held 81 shares of GSK worth $4.25K as of Q2 2026.
  • Ares Financial Consulting bought 47 GSK shares in Q2 2026, an estimated $2.49K.
  • GSK made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #752 holding.
  • Ares Financial Consulting first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • 576 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.